Enrica Marchi, MD
Hematologic Malignancy
Bio & Overview
Enrica Marchi, MD, PhD, is a medical oncologist who specializes in the research and treatment of blood cancer. She cares for patients with all types of malignant hematologic disease, particularly those with T-cell lymphomas. Her primary is on research to develop new treatment platforms for T-cell lymphoma.
Dr. Marchi is an accomplished researcher and has been involved in the discovery of novel therapeutic strategies in the laboratory that have now been translated into clinical trials for patients with T-cell lymphomas. Because of her expertise, she has been named co-director of the Program for T-Cell Lymphoma Research at UVA and the deputy director of the Global T-Cell Lymphoma Consortium (GTCLC). This consortium brings together top research scientists from around the world to advance the care of these rare forms of cancer.
Originally from Italy, Dr. Marchi attended medical school and completed her hematology fellowship at the Institute of Hematology and Clinical Oncology (L. & A. Seragnoli) at the University of Bologna in Bologna, Italy. She was a fully certified clinical hematologist in Europe when she moved to the U.S. to pursue a PhD at Columbia University in New York City.
During her PhD training, she investigated a number of novel drug combinations in the preclinical setting and brought the most promising one in clinical trials for patients with peripheral T-cell lymphoma (PTCL) and cutaneous T-cell lymphoma (CTCL). Dr. Marchi then decided to remain in the U.S. to continue her research and care for patients.
To do so, she had to repeat some of her training and become certified to practice medicine in the U.S. Dr. Marchi enrolled in a residency at Lincoln Hospital in New York and then completed her oncology fellowship training at Columbia University Medical Center in New York, where she joined the faculty of the Center for Lymphoid Malignancies.
Dr. Marchi joined the UVA team in 2020. In her free time, she enjoys world travel and has visited many countries, including Namibia, Rwanda, Brazil, Mongolia, Morocco, in addition to most European countries and many Caribbean islands. She also enjoys running and listening to a variety of music, from classical to electronic.
Academic Information
- Department
- Medicine
- Academic Role
- Associate Professor
- Division
- Hematology/Oncology
- Research Interests
- My research focus is in developing new treatment platforms for Peripheral T-Cell Lymphoma (PTCL) and Cutaneous T-Cell Lymphoma (CTCL). Special interest in translating the most promising pre-clinical data from the laboratory to early phase clinical trials.
- Gender
- Female
- Languages
- Spanish, Italian, English
- Age Groups Seen
- Adults (21-65)
Older Adults (65+)
- Primary Education
- University of Bologna
- Residency
- Lincoln Medical Center
- Fellowships
- Columbia University Medical Center
- Certification
- American Board of Internal Medicine (Medical Oncology), American Board of Internal Medicine (Internal Medicine)
Highlights
Meet Oncologist Enrica Marchi, MD
My name is Enrica Marchi and I'm an MD-PhD, part of the division of hematology and oncology at the University of Virginia. I care for patients with peripheral T-cell lymphoma and cutaneous T-cell lymphoma. My interest in medicine started when I was a kid, meeting my primary care doctor. I thought that doctors would be sort of, some sort of magician that could understand people's diseases, examining them, talking with them. And that's what initially intrigued me into medicine, and obviously grew with an interest that became then a scientific interest in diseases and how to treat them, and how to take care of patients with, specifically cancer. What interested me the most in medicine was what I thought, at the beginning, there were in between the most needy patients. So cancer patients for me in my mind, in my view and then as a medical student, seem to be extremely vulnerable and in need of care and better care. And that specifically interested me in the field of hematology-oncology. I'm very passionate about drug development. I'm very passionate about discovering new drugs or new combination of drug that can truly change the natural course of disease and life of my patient. Patients should come to UVA because at UVA, there is a great expertise in a number of disease. They really would find the top-notch doctors in the country here. They will find an incredibly skilled and experienced team of nurses, social workers, care coordinators, that will really be able to accompany them and lead their way through a difficult time in their life.
Reviews
203 Patient Satisfaction Ratings
Our patient satisfaction ratings are an average of all the survey responses to the below questions a provider got within the past 2 years. To protect your privacy, patients aren't identified.
See more about our patient satisfaction surveys .